留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

黄芩汤的拓展应用与适用人群特征

黄煌

黄煌. 黄芩汤的拓展应用与适用人群特征[J]. 南京中医药大学学报, 2022, 38(9): 761-764. doi: 10.14148/j.issn.1672-0482.2022.0761
引用本文: 黄煌. 黄芩汤的拓展应用与适用人群特征[J]. 南京中医药大学学报, 2022, 38(9): 761-764. doi: 10.14148/j.issn.1672-0482.2022.0761
HUANG Huang. Expanded Applications and Applicable Population Characteristics of Huangqin Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(9): 761-764. doi: 10.14148/j.issn.1672-0482.2022.0761
Citation: HUANG Huang. Expanded Applications and Applicable Population Characteristics of Huangqin Decoction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(9): 761-764. doi: 10.14148/j.issn.1672-0482.2022.0761

黄芩汤的拓展应用与适用人群特征

doi: 10.14148/j.issn.1672-0482.2022.0761
详细信息
    作者简介:

    黄煌,1954年生,全国名中医,南京中医药大学国际经方学院院长、教授、博士生导师,国家中医药管理局龙砂医学流派代表性传承人。20世纪80年代主要从事中医学术流派的教学与研究,90年代以后专注于经方方证的规范化研究和现代应用研究,并致力于经方的普及推广事业。提倡基于方证相应的“方-病-人诊疗模式”,强调中医的整体观念和全科思维,推进以《伤寒论》《金匮要略》方为核心的经方医学的国际化和大众化。代表性学术专著有《中医十大类方》《张仲景50味药证》《黄煌经方使用手册》《黄煌经方医话》《经方方证》等

    通讯作者:

    黄煌,男,教授,博士生导师,主要从事经方的方证与药证研究,E-mail:hhuang54@163.com

  • 中图分类号: R289.1

Expanded Applications and Applicable Population Characteristics of Huangqin Decoction

  • 摘要: 黄芩汤是治疗发热性疾病出现腹泻的经方,后来成为历代治疗热性腹泻的基本方。论文介绍了黄芩汤的拓展应用与适用人群特征。黄芩汤的应用除了《伤寒论》原文的记载外,在现代临床中还可用于发热性疾病、消化道疾病、妇产科疾病、自身免疫性疾病等;从适用人群看,黄芩汤多用于一种内热、伏热为特征的热性体质,女性多见,黏膜充血、烦热、肛肠证有特异性,由此构成黄芩汤方证。识别黄芩汤方证的临床思维,离不开适用疾病与适用人群这两个维度。

     

  • [1] 张大昌, 钱超尘. 辅行诀五脏用药法要传承集[M]. 北京: 学苑出版社, 2008: 69.

    ZHANG DC, QIAN CC. Essential Teachings on the Five Zang Organs[M]. Beijing: Academy press, 2008: 69.
    [2] 王孟英. 随息居重订霍乱论[M]. 长沙: 湖南科学技术出版社, 2014: 244.

    WANG MY. Revised Treatise on Sudden Turmoil by the Lay Buddhist Sui-Xi[M]. Changsha: Hunan science and technology press, 2014: 244.
    [3] 张璐. 伤寒缵论: 卷下[M]. 北京: 中国中医药出版社, 2015: 199.

    ZHANG L. Continued Treatise on Cold Damage: Volume 2[M]. Beijing: China press of traditional Chinese medicine, 2015: 199.
    [4] 柳宝诒. 温热逢源[M]. 北京: 人民卫生出版社, 1982: 65.

    LIU BY. Encountering the Sources of Warm-Heat Diseases[M]. Beijing: The people's medical publishing house, 1982: 65.
    [5] 庞安时. 伤寒总病论[M]. 北京: 人民卫生出版社, 2007: 75.

    PANG AS. General Treatise on the Diseases of Cold Damage[M]. Beijing: The people's medical publishing house, 2007: 75.
    [6] 张璐. 张氏医通[M]. 上海: 上海科学技术出版社, 1963: 911.

    ZHANG L. Comprehensive Medicine According to Master Zhang[M]. Shanghai: Shanghai scientific and technical publishers, 1963: 911.
    [7] 秦昌遇. 症因脉治[M]. 北京: 中医古籍出版社, 2000: 108.

    QIN CY. Symptoms, Causes, Pulses, and Treatment[M]. Beijing: Traditional Chinese medicine ancient books publishing house, 2000: 108.
    [8] 江笔花. 笔花医镜[M]. 上海: 上海卫生出版社, 1957: 73.

    JIANG BH. Medical Reflections from Jiang Bi-hua[M]. Shanghai: Shanghai medical publishing house, 1957: 73.
    [9] 汤本求真. 皇汉医学[M]. 北京: 中国中医药出版社, 2007: 253.

    TANGBEN QZ. Huanghan Medicine[M]. Beijing: China press of traditional Chinese medicine, 2007: 253.
    [10] 郭雍. 伤寒补亡论[M]. 北京: 中国书店, 1992: 516.

    GUO Y. Supplement to What had been Lost from the Treatise on Cold Damage[M]. Beijing: China bookstore, 1992: 516.
    [11] 张仲景. 金匮要略[M]. 北京: 人民卫生出版社, 2005: 82.

    ZHANG ZJ. Essentials from the Golden Cabinet[M]. Beijing: The people's medical publishing house, 2005: 82.
    [12] 郑永齐. 耶鲁药理学教授郑永齐: 古老中药是"解锁"癌症治疗的新可能[N]. 医师报, 2020-06-27.

    ZHENG YQ. Yale Pharmacology Professor Zheng Yong-qi: Traditional Chinese Medicine is a New Possibility for Cancer Treatment[N]. Physician's Daily, 2020-06-27.
    [13] KUMMAR S, COPUR MS, ROSE M, et al. A phase I study of the Chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer[J]. Clin Colorectal Cancer, 2011, 10(2): 1-96.
    [14] LAM W, BUSSOM S, GUAN F, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity[J]. Sci Transl Med, 2010, 2(45): 45.
    [15] SAIF MW, LI J, LAMB L, et al. First-in-human phase Ⅱ trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer[J]. Cancer Chemoth Pharm, 2014, 73(2): 373-380. doi: 10.1007/s00280-013-2359-7
    [16] 叶天士. 临证指南医案[M]. 上海: 上海科学技术出版社, 1959: 265.

    YE TS. Case Records as a Guide to Clinical Practice[M]. Shanghai: Shanghai scientific and technical publishers, 1959: 265.
    [17] 朱肱. 类证活人书[M]. 上海: 商务印书馆, 1955: 89.

    ZHU G. Book to Safeguard Life Arranged by Categorized Patterns[M]. Shanghai: The commercial press, 1955: 89.
    [18] 吴世昌. 奇方类编: 卷下[M]. 北京: 中医古籍出版社, 1986: 47.

    WU SC. Formulas of Wonderful Efficacy Arranged by Category: Volume 2[M]. Beijing: Traditional Chinese medicine ancient books publishing house, 1986: 47.
    [19] 李时珍. 本草纲目[M]. 北京: 人民卫生出版社, 2002: 545.

    LI SZ. The Grand Compendium of Materia Medica[M]. Beijing: The people's medical publishing house, 2002: 545.
    [20] 柯韵伯. 伤寒来苏集[M]. 上海: 上海科学技术出版社, 1959: 48.

    KE YB. Collected Writings on the Renewal of the Treatise on Cold Damage[M]. Shanghai: Shanghai scientific and technical publishers, 1959: 48.
    [21] 陈亦人. 伤寒论译释[M]. 上海: 上海科学技术出版社, 1992: 721.

    CHEN YR. Modern Interpretation and Annotations of the Treatise on Cold Damage[M]. Shanghai: Shanghai scientific and technical publishers, 1992: 721.
    [22] 李培生. 伤寒论讲义[M]. 上海: 上海科学技术出版社, 1985: 51.

    LI PS. Teaching Notes of the Treatise on Cold Damage[M]. Shanghai: Shanghai scientific and technical publishers, 1985: 51.
  • 加载中
计量
  • 文章访问数:  161
  • HTML全文浏览量:  32
  • PDF下载量:  25
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-07-15
  • 网络出版日期:  2022-09-19
  • 发布日期:  2022-09-10

目录

    /

    返回文章
    返回